Viewing Study NCT07266493


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2025-12-27 @ 10:49 AM
Study NCT ID: NCT07266493
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module